Genetic Testing
-
Finance
Genetic Testing Company 23andMe Going Public At $3.5 Billion Valuation, Focus On More Therapeutics
While personal genetic testing as entertainment slowed as a revenue source in recent years, 23andMe has doubled down on its therapeutic programs. -
Angelina Jolie, Antonin Scalia, Health Care / Medicine, Insurance, Intellectual Property, John Roberts, Patents, Samuel Alito, Supreme Court, Technology, Women's Issues
Yes, It Is Worth Making A Federal Case Over Angelina Jolie's Boobs
Angelina Jolie took action to address her cancer risk. If the Supreme Court gets its act together, more women can follow her example.
Hide This extra mobile ad.